Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS

Neurology

Volumn 60, Issue 8, 2003, Pages 1252-1258

  Ince, Paul G ^a,c   Evans, J ^a   Knopp, M ^a   Forster, G ^a   Hamdalla, H H M ^b   Wharton, S B ^a   Shaw, P J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b HULL ROYAL INFIRMARY   (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHLORDANE; UBIQUITIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN STEM; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MACROPHAGE; MALE; NERVE FIBER DEGENERATION; NEUROPATHOLOGY; PRIORITY JOURNAL; PROGRESSIVE MUSCULAR ATROPHY; PYRAMIDAL SIGN; SPINAL CORD;

EID: 0037461283     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000058901.75728.4E     Document Type: Article

References (41)

1. WFN Research Group on Neuromuscular Diseases Subcommittee on Motor Neurone Disease. Airlie house guidelines: therapeutic trials in amyotrophic lateral sclerosis. J Neurol Sci 1995;129(suppl):1-10.
2. Brooks B. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994;124(suppl):96-107.
3. Brooks B, Miller R, Swash M, Munsat T. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. ALS Other MND 2000;1:293-299.
4. Rowland L. Diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1998;160(suppl 1):S6-S24.
5. Troost D, Van Den Oord J, de Jong JMBV. Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 1990;16:401-410.
6. Lawyer T, Netsky M. Amyotrophic lateral sclerosis: a clinicopathological study of 53 cases. Arch Neurol Psychiatry 1953;69:171-192.
7. Lampson L, Kushner P, Sobel R. Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis. Ann Neurol 1990;28:365-372.
8. Hayashi H, Kato S. Total manifestations of amyotrophic lateral sclerosis (ALS) in the totally locked-in state. J Neurol Sci 1989;93:19-35.
9. Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry 1970;33:338-357.
10. Ince PG, Lowe J, Shaw PJ. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 1998;24:104-117.
11. Shaw PJ, Ince PG, Slade JY, Burn J, Cartlidge NEF. Lower motor neuron degeneration and familial predisposition to colonic neoplasia in two adult siblings. J Neurol Neurosurg Psychiatry 1991;54:993-996.
12. Smith M, Strich S, Sharp P. The value of the Marchi method for staining tissue stored in formalin for long periods. J Neurol Neurosurg Psychiatry 1956;19:62-83.
13. Leigh PN, Anderton BH, Dodson A, Gallo J-M, Swash M, Power D. Ubiquitin deposits in anterior horn cells in motor neurone disease. Neurosci Lett 1988;93:197-203.
14. Lowe J, Blanchard A, Morrell K, et al. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease and Alzheimer's disease as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic inclusion bodies in muscle and Mallory bodies in alcoholic liver disease. J Pathol 1988;155:9-15.
15. Ince PG, Tomkins J, Slade JY, Thatcher NM, Shaw PJ. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding superoxide dismutase: molecular pathology of five new cases and comparison with 73 sporadic cases and previous reports. J Neuropathol Exp Neurol 1998;57:895-904.
16. Lowe J, Lennox G, Jefferson D, et al. A filamentous inclusion body within anterior horn neurons in motor neuron disease defined by immunocytochemical localisation of ubiquitin. Neurosci Lett 1988;93:203-210.
17. Wightman G, Anderson V, Martin J, et al. Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett 1992;139:269-277.
18. Jackson M, Lennox G, Lowe J. Motor neurone disease-inclusion dementia. Neurodegeneration 1996;5:339-350.
19. Holton L, Révész T, Crooks R, Scaravilli F. Evidence for pathological involvement of the spinal cord in motor neuron disease-inclusion dementia. Acta Neuropathol 2002;103:221-227.
20. Iwanaga K, Hayashi S, Oyake M, et al. Neuropathology of sporadic amyotrophic lateral sclerosis of long duration. J Neurol Sci 1997;146:139-143.
21. Sasaki S, Iwata M. Motor neuron disease with predominantly upper extremity involvement: a clinicopathological study. Acta Neuropathol 1999;98:645-650.
22. Bunina TL. Intracellular inclusions in familial amyotrophic lateral sclerosis. Zh Neuropatol Psikhiatr Im S S Korsakova 1962;62:1293-1299.
23. Piao Y-S, Wakabayashi K, Kakita A, et al. Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol 2003;12:10-22.
24. Cudkowicz ME, McKenna-Yasek D, Chen C, Hedley-Whyte ET, Brown RH. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene. Ann Neurol 1998;43:703-710.
25. Cervenakova L, Protas I, Hirano A, et al. Progressive muscular atrophy variant of familial amyotrophic lateral sclerosis (PMA/ALS). J Neurol Sci 2000;177:124-130.
26. Rouleau GA, Clark AW, Rooke K, et al. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann Neurol 1996;39:128-131.
27. Shaw CE, Enayat ZE, Powell JF, et al. Familial amyotrophic lateral sclerosis: molecular pathology of a patient with a SOD1 mutation. Neurology 1997;49:1612-1616.
28. Schochet JS, Hardmann JM, Ladewig PP, Earle KM. Intraneuronal conglomerates in sporadic motor neuron disease. Arch Neurol 1969;20:548-553.
29. Sasaki S, Iwata M. Immunochemical and ultrastructural study of the motor cortex in patients with lower motor neuron disease. Neurosci Lett 2000;281:45-48.
30. Veltema A. The case of the saltimbanque Prosper Lecomte. A contribution to the study of the history of progressive muscular atrophy (Aran-Duchenne) and amyotrophic lateral sclerosis (Charcot). Clin Neurol Neurosurg 1975;78:204-209.
31. Aran FA. Recherches sur une maladie non encore décrite du système musculaire (atrophie musculaire progressive). Arch Gen Med 1850;24:5-35, 172-214.
32. Charcot JM, Joffroy A. Deux cas d'atrophie musculaire progressive avec lésions de la substance grise et des fascicaeux antérolateraux de la moelle épinière, Arch Physiol (Paris) 1869;2:354-367, 629-644, 744-760.
33. Charcot JM. De la sclérose latérale amyotrophique. Prog Med 1874;2:325-327, 341-342, 453-455.
34. Swank R, Putman T. Amyotrophic lateral sclerosis. Arch Neurol Psychiatry 1943;49:151-177.
35. Norris F. Adult progressive muscular atrophy. In: Vinkens P, et al., eds. Handbook of clinical neurology, vol 59, diseases of the motor system. Amsterdam: Elsevier, 1992;13-34.
36. Chio A, Brignolio F, Leone M, et al. A survival analysis of 155 cases of progressive muscular atrophy. Acta Neurol Scand 1985;72:407-413.
37. Tsuchiya K, Shintani S, Kikuchi M, et al. Sporadic amyotrophic lateral sclerosis of long duration mimicking spinal progressive muscular atrophy: a clinicopathological study. J Neurol Sci 1999;162:174-178.
38. Traynor B, Codd M, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 1999;52:504-509.
39. Norris F, Denys E, Sang K, Mukai E. The natural history of ALS in a specified population with comments on risk factors, prognosis and symptomatic treatments. Rinsho Shinkeigaku 1989;29:1485-1492.
40. Haverkamp L, Appel V, Appel S. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995;118:707-719.
41. Motara P, Chio A, Rosso M, Leone M, Schiffer D. Motor neuron disease in the province of Turin, Italy, 1966-1980. Survival analysis in an unselected population. J Neurol Sci 1984;66:165-173.